
A fictional mid-market B2B biotech SaaS company — benchmark-grounded to demonstrate the full diagnosis-to-activation workflow.
Disclosure: HelixFlow Clinical Operations Cloud is a fictional company. All data, metrics, scores, recommendations, and impact estimates are synthetic and illustrative only. The case is benchmark-grounded but does not represent a real client engagement or achieved outcome.
Company overview
HelixFlow is a fictional mid-market B2B biotech / life-science SaaS company serving biotech sponsors, CROs, and emerging medtech teams with a multi-module platform spanning clinical operations, site coordination, quality workflows, regulatory document tracking, and cross-functional program reporting.
HelixFlow is not in free fall. It is in a more commercially realistic mid-market pattern: GRR is under pressure at 89%, NRR is only 101%, module expansion exists but is inconsistent, onboarding takes too long for too many accounts, and renewal risk is discovered too late for high-quality intervention.
At HelixFlow's scale, a few points of gross retention quality matter. 11% gross revenue loss on $16.4M ARR implies roughly $1.8M of annual gross churn pressure — and a large share of the avoidable pain appears concentrated in a manageable minority of accounts.
Baseline metrics
Diagnosis
When bookings outpace implementation capacity, accounts queue up and time-to-value stretches.
Median days rise from low-80s toward 104 days — backlog-induced delivery delay visible to leadership.
Accounts land in the anchor module but do not broaden into deeper workflow embedment.
Support burden is not the original cause, but it amplifies weak onboarding by eroding trust and consuming reactive CS capacity.
Risk is surfaced too late for the best save motions — the business is not only missing risk, it is identifying it too late.
System dynamics
How onboarding backlog, time to first value, adoption depth, and revenue at risk reinforce one another across the post-sale system.

Fig. 1 — HelixFlow influence network. Nodes represent system stocks and delays; edges represent causal influence.
Reference modes
Reference modes capture the expected dynamic behavior of key metrics over time — grounding hypotheses in observable patterns.

GRR drifts from ~90.5% toward ~89.0% over three quarters — pressured but realistic retention deterioration.
Dynamic hypotheses
When bookings outpace implementation capacity, onboarding backlog lengthens time to first value. Delayed value realization reduces confidence before renewal and increases the probability that accounts enter the at-risk queue.
Support burden is not the original cause for most accounts, but it amplifies weak onboarding by eroding trust and consuming reactive CS capacity.
Champion turnover makes shallowly adopted accounts structurally fragile because workflow knowledge and business ownership do not transfer instantly.
The same delayed-value mechanism that raises renewal risk also suppresses second-module expansion attach rates. This explains why GRR pressure and uneven expansion coexist.
Impact model
The upside is intentionally conservative — it does not assume best-in-class retention, full elimination of churn, or anything beyond modest improvement in a concentrated high-risk cohort.
+1.5–2.0
points
GRR improvement
+2.0–3.0
points
NRR improvement
$250k–$330k
annually
Gross ARR protected
$580k–$830k
annually
Total modeled upside
Action activation
The recommendation policy combines account-level risk scores with operational context to route accounts into the right queue with the right action.
Example routing logic
Condition
Stalled onboarding + near renewal
Queue
implementation_recovery_queue
Action
Review and launch onboarding recovery plan
Condition
High risk + high value + renewal inside 60 days
Queue
renewal_save_queue
Action
Open renewal save plan with exec sponsor
Condition
High support burden
Queue
support_escalation_queue
Action
Assign executive support review
Condition
Low risk + high expansion propensity
Queue
expansion_readiness_queue
Action
Schedule success review
ML/AI posture
The downstream ML/AI strategy is explicitly labeled by posture. For HelixFlow, the recommendation is rules-first deterministic queue policy rather than immediate predictive sophistication.

Fig. 2 — Recommended downstream ML/AI posture. Rules-first deterministic queue policy and instrumentation-first approaches span all maturity levels.
Deliverables
The full client report compiles the complete artifact chain into a single executive-ready document.
Download full client reportExecutive diagnosis brief
Prospect-facing
Dynamic hypothesis brief
Prospect-facing
Business impact model
Prospect-facing
Influence network (static + interactive)
Prospect-facing
Reference-mode charts
Prospect-facing
Causal validation brief
Client-facing
Causal inference brief
Client-facing
ML/AI recommendation brief
Client-facing
Action activation brief
Prospect-facing
Relational risk brief
Client-facing
Model card
Client-facing
Technical implementation blueprint
Client-facing
Every engagement starts with a Diagnosis Sprint — mapping your specific retention and expansion dynamics with the same rigor demonstrated here.